BioMedNewsBreaks – InvestorBrandNetwork Announces Launch of Technology-Driven Communications Platform – BioMedWire

InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, today announced the launch of BioMedWire (“BMW”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. A laser-focused, technology-driven communications platform, BioMedWire is designed to provide the latest updates and information related to emerging market opportunities in the life sciences sector and beyond. “The life sciences sector has delivered incredible remedies and cures, saved and changed lives, and offered some of the greatest investment returns the markets have ever seen. The sector is constantly moving and evolving to meet the health and wellness challenges of the times, and BioMedWire is designed to keep investors abreast of developments and highlight companies in the sector that offer hope for improved quality of life,” Chris Johnson, director of client solutions for InvestorBrandNetwork, said in the news release. “By adding BioMedWire to our 45+ brands, we’re providing a powerful new platform for innovators in this space to speak directly to the investment community.”

To view the full press release, visit http://ibn.fm/jdumT

About InvestorBrandNetwork

The InvestorBrandNetwork (“IBN”) consists of financial brands introduced to the investment public over the course of 14+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.

For more information on IBN, visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — Zevra Therapeutics, Inc. (NASDAQGS: ZVRA) to Present New MIPLYFFA Data at ICIEM, Poster Earns Best Poster Award

Zevra Therapeutics (NASDAQGS: ZVRA), a commercial-stage company focused on therapies for rare diseases, announced that…

3 hours ago

BioMedNewsBreaks — Propanc Biopharma, Inc. (NASDAQ: PPCB) Closes $4 Million Public Offering 

Propanc Biopharma (NASDAQ: PPCB) announced the closing of its underwritten public offering of 1,000,000 shares…

9 hours ago

BioMedNewsBreaks — Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development

Lantern Pharma (NASDAQ: LTRN) recently unveiled a new artificial intelligence module designed to predict the…

1 day ago

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Showcases Pipeline and CEO’s Intellectual Property Legacy

Oncotelic Therapeutics (OTCQB: OTLC), a clinical stage biopharmaceutical company developing transformative oncology and immunotherapy treatments,…

1 day ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Profiled on Credit-Card-Sized Device That Synthesizes 12-Lead ECG 

HeartBeam (NASDAQ: BEAT) is the focus of a piece by Susan Shepard for MD+DI detailing…

1 day ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at Three September Investor Conferences

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, announced that CEO…

1 day ago